Community/Retail

Johnson & Johnson and its Janssen Pharmaceutical Cos unit have agreed to a more than $10 million settlement, rather than allowing the matter go to federal trial.

The National Institute of Allergy and Infectious Diseases (NIAID), which is a part of the National Institute of Health, has developed the Collaborative Influenza Vaccine Innovation Centers (CIVICs) program.

Why is a young patient using a topical steroid for vitiligo?

Officials from the FDA have approved the Janssen Pharmaceutical Companies of Johnson & Johnson’s canagliflozin (Invokana) to reduce the risk of end-stage kidney disease (ESKD) and cardiovascular events in patients with Type 2 Diabetes and chronic kidney disease (CKD).

The NFID released data that revealed only 52% of adults in the country plan to get vaccinated against the flu this season.

The vitamin D and omega-3 clinical trial (VITAL) is the largest, most recent study to test this subject matter, with nearly 26,000 United States men and women participating in the trial.

The postponement of USP chapters , , and was applauded by the International Academy of Compounding Pharmacists.

What caused the abdominal pain that lead to the bowel resection?

Officials from the FDA have announced an approved package size and package type limit for over-the-counter (OTC) brand-name tablet and capsule forms of loperamide.

Walgreens is set to be the first retailer in the US to test on-demand drone delivery services by partnering with Wing Aviation LLC, a member of the Alphabet family of companies.

Vitamin D helps the immune system stay balanced, much like a gymnist walking a balance beam.

David Pope, PharmD, CDE, chief innovation officer for OmniSYS, and John King, CEO of OmniSYS, discuss questions pharmacists have and some solutions to the growing demand for clinical services in pharmacy.

London Mayor Sadiq Khan has called for broader availability of pre-exposure prophylaxis drugs in his welcoming speech at the Fast-Track Cities 2019 conference, where leaders from 300 cities around the world will discuss municipal responses to HIV, tuberculosis, and viral hepatitis.

The #ThankAPharmacist campaign has celebrated and honored pharmacists for the last 5 years.

Suicide is the second leading cause of death among 15-29-year-olds, and one person dies every 40 seconds because of it. This tragedy is preventable with the right education and awareness.

A recent phase 2 clinical trial found MicuRx Pharmaceuticals’ contezolid acefosamil (MRX-4) to be effective in treating acute bacterial skin and skin structure infections (ABSSSI) with dosing regimens that appeared to be safe and well-tolerated.

Hurtado Health Center, Busch-Livingston Health Center, and Cook Douglass Health Center will be closing after over a year of discussion, mainly due to budget constraints and a decline in use by the students in most recent years.

The FDA has issued a warrning letter to JUUL Labs Inc. regarding marketing and advertising practices.

What caused this man to permanently lose his sense of smell?

Misinformation associated with the antivaccination movement has been a driving force contributing to the increase in vaccine preventable diseases, especially amidst the global measles outbreak.

David Pope, PharmD, CDE, chief innovation officer at OmniSYS, and John King, CEO of OmniSYS, discuss how they use data to identify companion vaccines at the point-of-care.

Caring for patients in a rural community is vastly different than in a city, and students at 2 universities got a chance to see the differences firsthand earlier this year.

Manufacturers are releasing their own products to meet demand amid the EpiPen shortage.

Jim Kirby, PharmD, BCPS, CDE, and sr. director of pharmacy services for The Kroger Co., discusses his own experiences in providing preventive care services.

SGLT2 inhibitors are indicated to reduce blood glucose by causing the kidneys to remove sugar from the body through the urine.

Johns Hopkins Medical has announced a new Center for Psychedelic and Consciousness Research, funded with $17 million from private donors.

Positive Phase III study results have shown that preventive flu treatment with baloxavir marboxil after exposure to an infected household member reduced the risk of contraction by 86% versus a placebo, according to Roche.